Hypoxic 3D-cultured umbilical cord mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hypoxic 3D-cultured umbilical cord mesenchymal stem cells, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA [Phase 1, Phase 2]